1,395.00
1,430.00
1,277.80
2,220.95
861.00
4,350.00
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
Current Price
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Gland Pharma Ltd is in the Pharmaceuticals sector with the Market Capitalization of worth Rs. 67,419.04 crores, it is incorporated in the year 1978. It has reported the consolidated sales of Rs. 1153.90 crores in June 2021. The company is also listed in the Bombay Stock Exchange (BSE) with the code 543245 and listed in the National Stock Exchange (NSE) with the code GLAND.
Glen Pharma Ltd was incorporated as Private Company in Hyderabad. The company is primarily involved in the production of injectable drugs. Gland Pharmaceuticals has a global presence in around 60 countries and operates on a business-to-business model in countries like India, the USA, Canada, Australia, and some European countries. Gland Pharma has a total of seven manufacturing units located in different parts of the country. Gland Pharmaceuticals has 1415 product registrations in multiple countries of the world, with 368 product registrations in the USA and 54 registrations in India. The company has all its
facilities approved by USFDA and has a track record of receiving no warnings. The promoters within the company currently hold 58.14% of the stake in the company.
The Foreign Institutional Investors (FII) and Domestic Institutional Investors (DII) holds 10.44% and 12.11% of the stake. The balance of 19.32% is by others (retail investors).
In June 2021, quarterly net sales were Rs. 1,153.90 crores, which has increased by approximately 31% from Rs. 884.21 crores for the April-June 2020 quarter. The quarterly net profit in June 2021 was Rs. 350.68 crores, which has seen a rise by nearly 12% from a net profit of Rs. 313.59 crores in June 2020. In June 2021, operating profit was reported at Rs. 1,137.44 crores, which is also increased by 33% as compared to an operating profit of Rs. 853.76 crores for the quarter ending in June 2020. From Rs. 20.24 in June 2020, the EPS of Gland Pharma Ltd has increased to Rs. 21.41 per share in June 2021. GLAND’s stock closed at Rs. 4131 on 16th August’2021 (NSE) and has returned 86.47% in the last six months and 126.06% in the last year.
Gland Pharma share price as on 01 May 2025 is Rs. 1400. Over the past 6 months, the Gland Pharma share price has decreased by 13.87% and in the last one year, it has decreased by 19.04%. The 52-week low for Gland Pharma share price was Rs. 1277.8 and 52-week high was Rs. 2220.95.
543245
GLAND
INE068V01023
Aug
You can buy Gland Pharma Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Gland Pharma Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Apr 30, 2025 03:57 PM the closing price of Gland Pharma Ltd was Rs.1,400.00.
The latest PE ratio of Gland Pharma Ltd as of Apr 30, 2025 03:57 PM is 32.71
The latest PB ratio of Gland Pharma Ltd as of Apr 30, 2025 03:57 PM is 0.38
The 52-week high of Gland Pharma Ltd share price is Rs. 2,220.95 while the 52-week low is Rs. 1,277.80
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Apr 30, 2025 03:57 PM, the market cap of Gland Pharma Ltd stood at Rs. 23,065.84 Cr.
We appreciate your patience. Your content is on the way.